Navigation Links
Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
Date:7/7/2008

e available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 84526379. The webcast and telephone replay will be available through July 21, 2008.

About Anadys

Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing ANA598, a non-nucleoside polymerase inhibitor, and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements". Such statements include, but are not limited to, references to (i) the expected timing and planned development activities for ANA773, including the timing for commencing dosing in the planned ANA773 HCV clinical trial; (ii) the belief that ANA773 has the potential to demonstrate benefit in patients infected with HCV; (iii) the belief that the TLR7 mechanism will potentially be complementary to ANA598; (iv) expectations regarding Anadys' cash utilization for 2008; (v) the planned study design of the two-part protocol of the ANA773 clinical trial in HCV; (vi) Anadys' expectation to begin dosing HCV-infected patients with ANA773 prior to the completion of the healthy volunteer portion of the study at a dose that will have demonstrated a desired magnitude of immune stimulation in the healthy subjects; and (vii) the belief that ANA773 can elicit immune stimulation of a magnitude sufficient to confer therapeutic potential without adverse safety issues. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
2. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
3. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
7. Isis Pharmaceuticals Conference Call Notice
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
10. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
11. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Today, humanity takes a massive step toward reaching our shared ... CONTACTS announces their new Apple Watch app which allows the ... Two taps. New contacts. From your watch. We live ... LensGauge which helps keep track of how long your lenses ... "Since our inception, we,ve been dedicated to providing our ...
(Date:4/24/2015)... new study shows an "alarming rise" over the last 20 ... progression of multiple sclerosis or reduce the frequency of attacks, ... & Science University (OHSU) and Oregon State University (OSU). ... in the marketplace over the past 20 years, paradoxically, did ... use those drugs. Researchers found the costs of all drugs ...
(Date:4/24/2015)... 2015  Span-America Medical Systems, Inc. (NASDAQ:  SPAN) ... 2015 second quarter results on Thursday, April 30, after ... company will conduct a conference call at 10:00 ... company,s financial and operating results for the second quarter ... the conference call will be available online at ...
Breaking Medicine Technology:Attention: We live in the future. Order contact lenses from your wrist with the 1-800 CONTACTS app for Apple Watch 2Researchers find alarming rise in cost of MS drugs over past two decades 2Researchers find alarming rise in cost of MS drugs over past two decades 3Researchers find alarming rise in cost of MS drugs over past two decades 4
... 2012 According to Marcia Crosse (Director, Health Care at ... protect American health has been compromised. In her comments on ... List, she says : "The Food ... health of all Americans. FDA,s role is far-reaching: from over-the-counter ...
... 2012   OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) ... their investigational compound OGX-427, in prostate and bladder cancer, ... Oncology (ASCO) 2012 Genitourinary Cancers Symposium, February 2-4, in ... compound designed to reduce levels of Heat Shock Protein ...
Cached Medicine Technology:Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 2Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 3Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 4OncoGenex Announces Presentation of OGX-427 Data at the ASCO 2012 Genitourinary Cancers Symposium 2OncoGenex Announces Presentation of OGX-427 Data at the ASCO 2012 Genitourinary Cancers Symposium 3
(Date:4/27/2015)... CA (PRWEB) April 27, 2015 Healthpointe ... invasive treatments for nail fungi and infections. Onychomycosis, which ... affect up to 10% of adults in the Western ... and irregularity in thickness. , Healthpointe’s Anaheim ... , a branch dedicated to providing quality skincare products ...
(Date:4/27/2015)... 2015 Texas has saved $433 million ... offenders to providing drug offenders with addiction treatment, according ... April 8th. Several states, including Massachusetts, are considering adopting ... Texas has formed community recovery programs to help redress ... Council of State Governments WA, ID, NE, KS, ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Consumer ... Top Service Providers in their respective sectors for Ottawa. ... this year’s winners; your dedication to superior service has ... across Canada, Consumer Choice Award gathers opinions, perceptions and ... businesses. All winners have gone through a rigorous selection ...
(Date:4/27/2015)... 2015 The Sanford J. Grossman Charitable ... Grossman, PhD, has committed $3 million to establish the ... Inflammatory Bowel Disease at the Icahn School of Medicine ... personalized medicine for treatment of Crohn’s disease, with the ... Crohn’s Disease, a chronic inflammatory disorder of the bowel ...
(Date:4/27/2015)... Viejo, CA (PRWEB) April 27, 2015 ... on top of footage with ProTelestrator from Pixel Film Studios. ... draw a freehand sketch over a moving or still video ... to diagram and analyze sports plays or incoming weather patterns. ... Mode" checkbox and then adjust the frame slider to control ...
Breaking Medicine News(10 mins):Health News:Southern California Healthpointe Clinics Now Treating Nail Fungus 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3Health News:2015 Ottawa Consumer Choice Award-Winners 2Health News:2015 Ottawa Consumer Choice Award-Winners 3Health News:2015 Ottawa Consumer Choice Award-Winners 4Health News:2015 Ottawa Consumer Choice Award-Winners 5Health News:2015 Ottawa Consumer Choice Award-Winners 6Health News:2015 Ottawa Consumer Choice Award-Winners 7Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 2Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 3Health News:Pixel Film Studios releases ProTelestrator for Final Cut Pro X. 2
... , HARRISBURG, Pa., Nov. 23 United Concordia ... today launched its newly redesigned Web site, www.unitedconcordia.com ... producers, employers and dentists. , "The site boasts ... all geared toward helping visitors find information quickly ...
... , SAN DIEGO, Nov. 23 Victory Pharma, Inc. ("Victory") ... further extension of Victory,s NAPRELAN franchise. , NAPRELAN Dose Card ... moderate pain and inflammation associated with primary dysmenorrhea ... for patients suffering from rheumatoid arthritis or osteoarthritis who may ...
... starting to have sex, CDC report says , MONDAY, Nov. ... U.S. teenage girls have had a sexually transmitted disease (STD), ... government report shows. , "The high burden of STDs among ... study author Dr. Sami L. Gottlieb, from the division of ...
... System study has found that one out of five Type ... more overweight. Researchers reported that 62.4 percent of U.S. ... are morbidly obese. Among African American adults with Type 2 ... of morbid obesity among people with diabetes is increasing at ...
... ... Agency Honored by Association of Marketing and Communication Professionals , ... Salem, MA (PRWEB) November ... that it has received the 2009 MarCom Gold Award in the design/website homepage ...
... Nurtur Receives Accreditation for Five Population Health Programs ... Institute (PHII), a non-profit 501(c)(3) organization, is pleased to announced ... Accreditation Program, v 1.0 (H-TAP(TM)) after two years of development. ... Farmington, CT is the first organization to receive the H-TAP ...
Cached Medicine News:Health News:United Concordia Dental Redesigns Web Site To Provide Improved Access To Information 2Health News:Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card 2Health News:One in Four Teen Girls Have STDs 2Health News:One in Four Teen Girls Have STDs 3Health News:Diabetics show alarming increase in morbid obesity 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 2Health News:LaVoie Group Wins 2009 MarCom Gold Award for Rockwell Medical Homepage Redesign 3Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: